CVS Health Gelecekteki Büyüme
Future kriter kontrolleri 1/6
CVS Health kazanç ve gelirin sırasıyla yıllık 9.1% ve 4.8% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 9.6% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 11.6% olacağı tahmin edilmektedir.
Anahtar bilgiler
9.1%
Kazanç büyüme oranı
9.6%
EPS büyüme oranı
| Healthcare kazanç büyümesi | 20.1% |
| Gelir büyüme oranı | 4.8% |
| Gelecekteki özkaynak getirisi | 11.6% |
| Analist kapsamı | Good |
| Son güncelleme | 23 Oct 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet
Nov 03
CVS Health Stock Dip: Undervalued And Ready For A Turnaround
Oct 24CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 12/31/2026 | 407,760 | 8,780 | 11,581 | 14,212 | 17 |
| 12/31/2025 | 386,282 | 7,739 | 10,419 | 12,276 | 23 |
| 12/31/2024 | 369,249 | 6,275 | 9,269 | 10,979 | 23 |
| 6/30/2024 | 361,855 | 7,190 | 5,273 | 8,072 | N/A |
| 3/31/2024 | 359,662 | 7,321 | 8,139 | 10,891 | N/A |
| 12/31/2023 | 356,623 | 8,344 | 10,395 | 13,426 | N/A |
| 9/30/2023 | 346,601 | 8,632 | 11,302 | 14,110 | N/A |
| 6/30/2023 | 338,072 | 2,965 | 17,674 | 20,517 | N/A |
| 3/31/2023 | 329,915 | 4,093 | 17,392 | 20,052 | N/A |
| 12/31/2022 | 321,629 | 4,311 | 13,450 | 16,177 | N/A |
| 9/30/2022 | 314,343 | 3,283 | 19,498 | 22,134 | N/A |
| 6/30/2022 | 306,933 | 8,287 | 15,868 | 18,532 | N/A |
| 3/31/2022 | 298,770 | 8,041 | 16,194 | 18,936 | N/A |
| 12/31/2021 | 290,912 | 8,001 | 15,745 | 18,265 | N/A |
| 9/30/2021 | 283,981 | 7,586 | 15,191 | 17,827 | N/A |
| 6/30/2021 | 277,285 | 7,212 | 11,618 | 14,180 | N/A |
| 3/31/2021 | 270,115 | 7,404 | 12,928 | 15,452 | N/A |
| 12/31/2020 | 267,908 | 7,188 | 13,428 | 15,865 | N/A |
| 9/30/2020 | 265,285 | 7,951 | 12,641 | 14,932 | N/A |
| 6/30/2020 | 262,980 | 8,257 | 13,628 | 15,986 | N/A |
| 3/31/2020 | 260,961 | 7,217 | 11,722 | 14,205 | N/A |
| 12/31/2019 | 255,765 | 6,629 | 10,391 | 12,848 | N/A |
| 9/30/2019 | 243,331 | 4,464 | 10,218 | 12,693 | N/A |
| 6/30/2019 | 226,053 | 4,324 | 8,448 | 10,862 | N/A |
| 3/31/2019 | 209,623 | -174 | 6,187 | 8,458 | N/A |
| 12/31/2018 | 193,919 | -597 | 6,828 | 8,865 | N/A |
| 9/30/2018 | 188,055 | 3,098 | 4,292 | 6,250 | N/A |
| 6/30/2018 | 186,967 | 2,989 | 5,822 | 7,764 | N/A |
| 3/31/2018 | 185,944 | 6,645 | N/A | 6,829 | N/A |
| 12/31/2017 | 184,765 | 6,606 | N/A | 8,007 | N/A |
| 9/30/2017 | 182,351 | 5,029 | N/A | 10,264 | N/A |
| 6/30/2017 | 180,785 | 5,281 | N/A | 11,587 | N/A |
| 3/31/2017 | 178,825 | 5,108 | N/A | 11,235 | N/A |
| 12/31/2016 | 177,526 | 5,291 | N/A | 10,141 | N/A |
| 9/30/2016 | 172,701 | 5,084 | N/A | 11,591 | N/A |
| 6/30/2016 | 166,729 | 4,781 | N/A | 9,477 | N/A |
| 3/31/2016 | 160,173 | 5,126 | N/A | 8,867 | N/A |
| 12/31/2015 | 153,290 | 5,202 | N/A | 8,539 | N/A |
| 9/30/2015 | 149,199 | 5,027 | N/A | 8,264 | N/A |
| 6/30/2015 | 145,577 | 4,741 | N/A | 8,089 | N/A |
| 3/31/2015 | 143,010 | 4,713 | N/A | 7,949 | N/A |
| 12/31/2014 | 139,367 | 4,626 | N/A | 8,137 | N/A |
| 9/30/2014 | 135,142 | 4,576 | N/A | 6,252 | N/A |
| 6/30/2014 | 132,053 | 4,887 | N/A | 6,310 | N/A |
| 3/31/2014 | 128,699 | 4,775 | N/A | 6,315 | N/A |
| 12/31/2013 | 126,761 | 4,600 | N/A | 5,783 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: CVS 'nin tahmini kazanç büyümesi (yıllık 9.1% ) tasarruf oranının ( 2.5% ) üzerindedir.
Kazançlar ve Piyasa: CVS şirketinin kazançlarının (yıllık 9.1% ) US pazarından (yıllık 15.2% ) daha yavaş büyümesi öngörülüyor.
Yüksek Büyüme Kazançları: CVS şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.
Gelir ve Pazar: CVS şirketinin gelirinin (yıllık 4.8% ) US pazarından (yıllık 8.8% ) daha yavaş büyümesi öngörülüyor.
Yüksek Büyüme Geliri: CVS şirketinin gelirinin (yıllık 4.8% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: CVS 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 11.6 %).